Region: International

UK Supreme Court judge and IP Hall of Fame inductee Lord Kitchin announces retirement

From the archives: Lord Kitchin's in-depth interview with IAM

03 February 2023

Neglect begets opportunity in femtech IP

Femtech entrepreneurs can take advantage of large empty spaces on the patent landscape to secure IP protection for their innovations

02 February 2023

Report finds ‘privateers’ charging royalties 15 times that of major SEP holders

Stout’s research identifies Panasonic, Nokia and Ericsson as the biggest sellers to privateers in the past decade

01 February 2023

Your practical guide to obtaining patent protection for software

Mewburn Ellis' James Leach provides a three-step approach to patenting software inventions

25 January 2023

We are willing to litigate our CRISPR patents, says IP chief on the CVC side

ERS Genomics’ Michael Arciero shares his views on the Cas9 licensing landscape in an exclusive IAM interview

24 January 2023

Opus audio codec pool launches with royalty discount for early adopters

Pool operator Vectis IP offers a licence to 300 Fraunhofer and Dolby patents for €15c per hardware device – but those quick to move unlock a 33% discount

16 January 2023

Royalty Pharma strikes another $1 billion dollar deal to acquire patent-backed revenue rights

Sales of drug earnings streams is an increasingly popular means of monetising life sciences innovations

10 January 2023

Novartis $245 million pay-out is latest reminder of pay-for-delay risks

Patent litigation settlements face increasingly dangerous antitrust pitfalls

09 January 2023

Four developments to watch out for in the mRNA patent wars this year

Disputes over vaccine technology will continue to occupy headlines in 2023

03 January 2023

The five stories that made 2022 a pivotal year for life sciences IP

IAM looks back at the most important pharmaceuticals developments of the past 12 months

28 December 2022

Unlock unlimited access to all IAM content